Treatment of Vaginal Candidiasis

Diagnosis and Treatment

The Centers for Disease Control and Prevention recommends that vaginal candidiasis with symptoms of white discharge and dryness should be treated with either a topical azole antifungal or oral fluconazole, with both options providing effective relief in 80-90% of uncomplicated cases 1, 2
Vaginal candidiasis is characterized by pruritus, white discharge, vaginal soreness, vulvar burning, dyspareunia, and external dysuria, and diagnosis is confirmed when a woman has symptoms of vaginitis plus either wet preparation or Gram stain showing yeasts/pseudohyphae, or positive culture for yeast species 3, 1, 2
The American College of Obstetricians and Gynecologists recommends using 10% KOH in wet preparations to improve visualization of yeast and mycelia 3

The Centers for Disease Control and Prevention recommends over-the-counter intravaginal agents such as clotrimazole 1% cream, clotrimazole 2% cream, miconazole 2% cream, miconazole 4% cream, miconazole 100mg vaginal suppository, miconazole 200mg vaginal suppository, and miconazole 1200mg vaginal suppository for the treatment of vaginal candidiasis 1
The Infectious Diseases Society of America recommends prescription intravaginal agents such as butoconazole 2% cream, terconazole 0.4% cream, terconazole 0.8% cream, and terconazole 80mg vaginal suppository for the treatment of vaginal candidiasis 1
A single oral dose of fluconazole 150mg is as effective as multi-day topical treatments for the treatment of vaginal candidiasis 1, 2

Both topical azoles and oral fluconazole provide relief of symptoms and negative cultures in 80-90% of patients who complete therapy, according to the Centers for Disease Control and Prevention 3, 2
Single-dose treatments are appropriate for mild-to-moderate cases, while multi-day regimens (3-day and 7-day) are preferred for severe or complicated vaginal candidiasis, as recommended by the American College of Obstetricians and Gynecologists 4, 2

Women with recurrent vaginal candidiasis (≥4 episodes/12 months) have lower cure rates with standard therapy and may require longer treatment courses, according to the Infectious Diseases Society of America 1
Topical azoles are generally preferred during pregnancy, as recommended by the American College of Obstetricians and Gynecologists 3
Patients with HIV should receive the same treatment as those without HIV, according to the Centers for Disease Control and Prevention 3

Patients should return for follow-up only if symptoms persist after completing treatment or if symptoms recur within 2 months, as recommended by the Centers for Disease Control and Prevention 2
Any woman whose symptoms persist after using an OTC preparation or who experiences recurrence within 2 months should seek medical care, according to the American College of Obstetricians and Gynecologists 3, 2